Health Care·Health Care Equipment·$45.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.95 | N/A | +18.75% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.95 | N/A | +18.75% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on their operational strengths. However, they acknowledged external pressures affecting the market.
Management highlighted strong performance in their core business segments.
They expressed confidence in their long-term growth strategy despite current market challenges.
IDEXX Labs reported better-than-expected earnings per share, which indicates strong profitability. However, the stock fell by 3% following the report, likely due to the lack of revenue details and guidance. Investors may be cautious given the absence of forward-looking statements from management.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AT&T INC
Jan 27, 2015